drug · small molecule
patient view →belzutifan
Marketedupdated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 3 investigational indications.
targets
Endothelial PAS domain-containing protein 1
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that